Stay updated with breaking news from Tme Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
25.04.2023 - Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced today its financial results for the ... Seite 1
24.04.2023 - Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announced today its financial results ... Seite 1
18.04.2023 - Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announces the publication of ... Seite 1
24.02.2023 - Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), released today a message from Aram Mangasarian, CEO ... Seite 1